CatalystWireBeta

UK small-cap RNS · 23 Sep 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies
  1. 16:56
    Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Consider Approval of Sale of Colombian and Ecuadorian Businesses
    23, 2026 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc.
    Moved: Sale of Colombia and Ecuador: Noteholder consents obtained; other conditions pending → Proxy filed; stockholder vote set for 9 October
  2. 16:29
    Holding(s) in Company Holding
  3. 16:07
    Statement re Possible Offer Offer
    Ember's fourth unsolicited cash proposal, at 615p, is the first the Board is engaging with (due diligence information, advisers). It follows two rejections and comes after two guidance cuts, so it offers an exit from the Middle East headwinds.
    Takeover target first since Oct 2023 +60.3% on the day
    Moved: new: Offer for the company – Possible offer; Board considering, due diligence
  4. 14:04
    PDMR/PCA Dealing Director dealing
    Palace Capital (LSE: PCA) announces the sale of ordinary shares of 10 pence each in the Company ("Shares") from Lakestreet Capital Partners AG ("Lakestreet Capital") to Lakestreet Trading AG ("Lakestreet Trading").
    Insider conviction first in 2 year +2.9% on the day
  5. 13:29
    PDMR - Correction Director dealing
    The following amendments have been made to the ‘PDMR and Director Dealings' announcement released on 24 April 2025 at 09:59:36 under RNS No 0494G (“Announcement”).
    Insider conviction 3 director buys in 3 months – usually less than 1 −0.6% on the day
  6. 12:30
    Annual General Meeting arrangements
    System1 www.system1group.com, the marketing decision-making platform, announces that, while it remains in an offer period, no questions or statements will be taken from the floor at the Annual General Meeting to be held on 25 September 2026.
    Takeover target +0.0% on the day
  7. 09:39
    Announcement regarding media speculation
    Board has begun assessing strategic options to deliver greater value for shareholders, including a take-private, following solid H1 fundraising. This puts a possible exit on the table for shareholders.
    Sale process / strategic review first since Oct 2023 +12.5% on the day
    Moved: new: Strategic review and possible offer – Strategic review; very early talks with third parties · Fundraising towards £10bn AuM: AuM £8.5bn; Fund IV closed, Fund VI prep → Continuing; strategic review announced
  8. 07:00
    Director/PDMR Shareholding Director dealing
  9. 07:00
    Director/PDMR Shareholding Director dealing
  10. 07:00
    Pre-close Trading update and Board change Trading update
    Guided FY26 loss before tax of c.£1.0m against consensus profit of £0.1m, and revenue of c.£70.0m against £79.0m, after the Board had reiterated in-line guidance in May. Slower H2 conversion reverses the second-half-weighted recovery.
    Upgrade / downgrade cycle below expectationsoutlook mixed, loweredfirst since Oct 2023 −8.7% on the day
    Moved: Return to growth and profitability: Loss narrowing to £0.8m; second-half weighted → Profit warning; loss of c.£1.0m vs consensus profit · Coleman AMP8 water ramp-up: Early-stage activity; start slower than expected → Timing of activity hit Coleman; H2 conversion slow · new: Board and leadership restructuring – CEO role removed; search for NED begun
  11. 07:00
    2026 Interim Results Results
    Interim revenue rose to $85.5m before a $3.7m hedging loss, cash rose and the company is debt free. Production was flat and 2026 guidance was narrowed with a lower midpoint because Egypt is weaker. The pending cash offer limits the impact.
    Disposal of a part (break-up) in lineoutlook mixed, loweredfirst in 6 months −0.7% on the day
    Moved: Offer for the company: Shareholders approved; regulatory conditions and court sanction pending → Shareholders approved; regulatory consents and court sanction pending · Vietnam six-well drilling programme: Five of six wells done; CNV-5X finishing → Six wells done; TGT-20X to spud late September · Egypt concession and work programme: First of six wells drilled; tie-back pending → Two of six wells drilled; third rig mobilising
  12. 07:00
    Half-year Results Results
    H1 underlying revenue growth slowed to 11% from 30% in FY25, with margin down to 29.4% and operating profit down 43% underlying. Results confirm the July guidance cut, so the growth story is weaker.
    Capital return outlook mixedfirst in 6 months +7.3% on the day
    Moved: Assess a further buyback after 30 April 2025.: on_track → delivered – Board approved a buyback extension on 8 July 2026 for up to a further 8m shares, following 9.5m shares bought in H1. · Share buyback programme: 9.6m shares repurchased in H1; extension planned → Extension approved; up to 8m more shares · FY26 growth slowdown and delays: guidance cut; H1 growth c.11% → H1 confirmed; delayed launches now live
  13. 07:00
    Half-year Results Results
    FY26 revenue is now guided to £38m with EBITDA of £1.4m as a further £7m of production slips into 2027 because of the Iran war. It follows the July slippage and the £1.9m FY25 EBITDA base, though the Middle East growth partly offsets it.
    Upgrade / downgrade cycle ahead of expectationsoutlook mixed, loweredfirst since Oct 2023 −10.1% on the day
    Moved: Medium-term £50m revenue, £5m EBITDA targets: FY26 secured revenue lower, H2-weighted, some slippage → FY26 guidance cut to £38m revenue, £1.4m EBITDA · Middle East expansion: Exchanged; completion delayed by Qatari mourning period → Exchanged; completion expected before end of October
  14. 07:00
    Kabwe Drilling (“KBDD01-05”) Results Results
    ALS Laboratories Confirm Scale and High-Grade Drilling Results at Pit 2 of the Kabwe Project
    Project milestones ahead of expectationsoutlook positive −2.6% on the day
    Moved: Kabwe drilling programme: Phase 1 drilling complete; assays and reporting pending → Pit 2 lab assays confirm pXRF grades
  15. 07:00
    Strategic Tungsten Supply and Offtake Agreement
    Binding eight-year offtake with US processor Elmet for 1,000t WO3 a year gives Hemerdon a long-term route to market just as production starts; value is indicative only, not guaranteed revenue.
    Transformational contract / build-out £1,400.0m · 255% of mcapfirst since Oct 2023 +4.9% on the day
    Moved: new: Elmet tungsten offtake agreement – Binding eight-year agreement signed · Hemerdon Project Financing: Ore processing started; ramp-up under way → Production under way; offtake signed
  16. 07:00
    Bretana Development Drilling Resumes
    Drilling restarted a week early with the first new Bretana well since January 2025, and injection capacity and September output both rose after a weak run of monthly production.
    Project milestones outlook positive3 signals in 3 months – usually less than 1 +0.0% on the day
    Moved: Bretana drilling restart and water handling: Pulling done; Estrella on site; injection workovers → Well 25H spud 21 Sept; drilling under way
  17. 07:00
    Ntorya Operations Update
    Aminex is pleased to provide an operational update on the Ntorya gas development.
    Project milestones outlook mixed +5.1% on the day
    Moved: Ntorya gas field development: Government-backed schedule agreed; dispute notice still open → JV approved revised 2026 and provisional 2027 budgets
  18. 07:00
    Half-year Results Results
    H1 loss was flat at about US$0.4m, helped by a US$333k derivative fair value gain. Cash rose to US$0.8m after the January raise and liabilities fell, but there is still no revenue.
    Disposal of a part (break-up) 3% of mcapoutlook mixedfirst in 8 months −7.5% on the day
    Moved: USA projects strategic options review: Binding sale agreement signed, conditional on ASX re-listing → Conditional agreement; awaiting GoldOz re-listing · Jelani joint venture and mining licence: Application accepted 7 May 2026; processing under way → Application accepted; statutory process under way · Kroonstad Phase 1 drilling design: Data review under way → Shango data capture and QA/QC under way
  19. 07:00
    Unaudited results for the period ended 30/06/2026 Results
    Focused execution against clear Strategic Priorities translating into continued strong financial performance:
    Upgrade / downgrade cycle ahead of expectationsfirst in 7 months +5.4% on the day
  20. 07:00
    Unaudited Interim Results Results
    Revenue rose to US$2.0m and the loss narrowed to US$1.8m, but the prior-year comparison was inflated by US$4.8m of exploration costs. Admin costs tripled and the company is still loss-making ahead of first own-ore gold.
    Large acquisition / reverse takeover first in 7 months −3.6% on the day
    Moved: Hillside gold development and plants: Plant installed; commissioning under way since 1 July → Commissioning under way; revenue still from artisanal ore · Nara Gold Project acquisition: Deed of Variation signed; completion anticipated shortly → Completion formalities ongoing
  21. 07:00
    Half-year Results Results
    H1 revenue fell 0.2% at constant currency and the headline loss widened to £4.5m, but the company says both were planned and in line, with no change to the plan set at the June raise.
    Dilutive fundraise in lineoutlook mixedfirst since Oct 2023 +0.0% on the day
    Moved: Transformation plan: Leadership change: interim CFO replaces departing CFO → H1 delivered; FY26 operational targets in progress · US tariffs and net debt: Net debt cut to £6.2m; equity raise completed → Net debt cut to £6.2m; ABL signed · Wax Lyrical disposal: Profit improvement plan before disposal → Profit improvement plan under way
  22. 07:00
    Half-year Results Results
    Unaudited interim results for the six months ended 30 June 2026
    Upgrade / downgrade cycle below expectationsfirst since Oct 2023 −4.4% on the day
  23. 07:00
    Half-year Results Results
    H1 revenue rose 8% to £22.8m, in line with expectations, and the adjusted EBITDA loss narrowed to £6.8m from £11.3m after cost cuts. The 2026 contracted revenue guide of c.£45m is reiterated and cash is £172.0m after the raise.
    Transformational contract / build-out £22.8m · 4% of mcapin lineoutlook positivefirst in 6 months +0.5% on the day
    Moved: £100m capital raise: Priced and oversubscribed; awaiting Admission → Completed; funds in H1 cash balance (closed) · Doosan SOFC export order: Doosan contract with Reverion noted by Ceres → Confirmed in interim results as Doosan's first export · Delta Taiwan factory build-out: Land and factory facilities acquired → Delta approved NTD10.3bn investment; build-out under way
  24. 07:00
    Half-year Results Results
    H1 revenue fell to £2.2m from £3.5m as a MeyGen turbine was off for servicing, the loss before tax stayed at £4.7m and cash was only £3.6m, so funding remains a priority.
    Balance-sheet stress / refinancing £7.8m · 65% of mcapoutlook mixedfirst in 12 months −4.3% on the day
    Moved: AW1 battery expansion: Nearing financial close; half of sale funds ringfenced → Planned after AW1 completion; stake sale completed · AW1 battery construction: Balance of plant and electrical works on schedule → Construction progressing in line with programme · new: MeyGen turbine redeployment – Turbine serviced onshore; three turbines operating
  25. 07:00
    KRM22 KRM £20m
    New Customer Contract
    Second software vendor adopts Risk Manager in a three-year £0.9m deal, lifting ARR to £8.4m. It eases the slow H1 sales conversion, though the value is small and spread over three years.
    Upgrade / downgrade cycle £0.9m · 4% of mcap +4.5% on the day
    Moved: Slower 2026 sales conversion: Delays persist; H1 net new ARR only £0.3m → New win; ARR £8.4m versus £7.9m at H1
  26. 07:00
    Equity Subscription Update Fundraise
    Nativo Resources plc (LON: NTVO), the precious metals company with gold mining and processing interests in Peru, is pleased to confirm the issue of the 142,857,143 Tranche B Subscription Shares to investors introduced by Chancery, raising £300,000.
    Dilutive fundraise −8.7% on the day

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note